Medical Writing Preclinical Studies Medical Communications

Volume 26, Issue 4 - Preclinical Studies

Medical Communications

Abstract

Dear all,

The legal side of our job is something that most of us usually give little thought to. We assume that as scientists, we are automatically on the “right side” and therefore pretty bulletproof. Why should the law affect us, as long
as we have the data to back us up? However, the reality is that this is a huge and complicated issue that can land not only medical writers, but their clients or companies in very deep hot water, very quickly. Considering the high stakes in the pharmaceutical industry and the highly competitive environment, it shouldn’t be a surprise that rival company lawyers monitor all information coming from competitor companies, but the extent of liability that we have as medical writers might surprise and possibly scare you.  In this issue, we hear from Joanne Flitcroft.  Joanne is a lawyer who has worked in the pharmaceutical industry for 17 years. She specialises in navigating the very tricky waters of defending product safety issues and maintaining corporate reputations. In her article, she explains some common pitfalls and why we should all be paying very close attention to the legal side of our work and its implications. With Joanne’s guidance, we will hopefully stay on the “right side” of the law and protect both ourselves and our clients/companies.

I’m sure you will enjoy her article, and it only leaves me to wish you the best wishes for the season – a happy and healthy 2018, and I hope Santa is kind to you all.

Bestest,
Lisa

Search

Articles

Preclinical studies
President’s Message
EMWA celebrates 25 years
EMWA News
Preclinical research in drug development
An introduction to little-known aspects of nonclinical regulatory writing
Reporting of preclinical research: What do we get told – when and how?
Mind the gap – towards complete and transparent reporting of animal research
The reproducibility crisis in preclinical research – lessons to learn from clinical research
Nonclinical studies in the Russian Federation — Problems, regulatory norms, and harmonisation with international standards
How to survive Brexit as an independent medical writer
Creation of a patient-centric patient lay summary in the local language
Six communication rules for scientific presentations and writing
So, you want to be a medical journalist?
News from the EMA
Profile: An interview with Steven Walker
Getting Your Foot in the Door
In the Bookstores
Journal Watch
The Webscout
Good Writing Practice
Medical Communications
Out on Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief

Raquel Billiones

Co-Editors

Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Deputy Managing Editor

Alicia Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Clare Chang

Barbara Grossman

Joselita T. Salita

Amy Whereat

Section Editors

Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News       

Aurélie Gobet / Paolo Rega

Gained in Translation

Raquel Billiones

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh / Stephen Gilliver

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Phil Leventhal

Manuscript Writing

Lisa Chamberlain-James

Medical Communications/Writing for Patients

Namrata Upadhyay

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Laura Kehoe

Out on Our Own

Jennifer Clemens

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Kimi Uegaki

The Crofter: Sustainable Communications

Karim Montasser

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Lay out Designer

Chris Monk